|
1
|
Hurtado A, Tseng JC and Meruelo D: Gene
therapy that safely targets and kills tumor cells throughout the
body. Rejuvenation Res. 9:36–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tseng JC, Hurtado A, Yee H, Levin B,
Boivin C, Benet M, Blank SV, Pellicer A and Meruelo D: Using
sindbis viral vectors for specific detection and suppression of
advanced ovarian cancer in animal models. Cancer Res. 64:6684–6692.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tseng JC, Levin B, Hurtado A, Yee H, Perez
de Castro I, Jimenez M, Shamamian P, Jin R, Novick RP, Pellicer A
and Meruelo D: Systemic tumor targeting and killing by Sindbis
viral vectors. Nat Biotechnol. 22:70–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang J, Frolov I and Russell SJ: Gene
therapy for malignant glioma using Sindbis vectors expressing a
fusogenic membrane glycoprotein. J Gene Med. 6:1082–1091. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mettler NE, Clarke DH and Casals J: Virus
inoculation in mice bearing Ehrlich ascitic tumors: antigen
production and tumor regression. Infect Immun. 37:23–27.
1982.PubMed/NCBI
|
|
6
|
Wollmann G, Tattersall P and van den Pol
AN: Targeting human glioblastoma cells: comparison of nine viruses
with oncolytic potential. J Virol. 79:6005–6022. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Unno Y, Shino Y, Kondo F, Igarashi N, Wang
G, Shimura R, Yamaguchi T, Asano T, Saisho H, Sekiya S and
Shirasawa H: Oncolytic viral therapy for cervical and ovarian
cancer cells by Sindbis virus AR339 strain. Clin Cancer Res.
11:4553–4560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strauss JH and Strauss EG: The
alphaviruses: gene expression, replication, and evolution.
Microbiol Rev. 58:491–562. 1994.PubMed/NCBI
|
|
9
|
Kurkela S, Manni T, Myllynen J, Vaheri A
and Vapalahti O: Clinical and laboratory manifestations of Sindbis
virus infection: prospective study, Finland, 2002–2003. J Infect
Dis. 191:1820–1829. 2005.PubMed/NCBI
|
|
10
|
Kurkela S, Manni T, Vaheri A and Vapalahti
O: Causative agent of Pogosta disease isolated from blood and skin
lesions. Emerg Infect Dis. 10:889–894. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Laine M, Luukkainen R and Toivanen A:
Sindbis viruses and other alphaviruses as cause of human arthritic
disease. J Intern Med. 256:457–471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Niklasson B, Espmark A, LeDuc JW, Gargan
TP, Ennis WA, Tesh RB and Main AJ Jr: Association of a Sindbis-like
virus with Ockelbo disease in Sweden. Am J Trop Med Hyg.
33:1212–1217. 1984.PubMed/NCBI
|
|
13
|
Greene IP, Wang E, Deardorff ER, Milleron
R, Domingo E and Weaver SC: Effect of alternating passage on
adaptation of sindbis virus to vertebrate and invertebrate cells. J
Virol. 79:14253–14260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kerr PJ, Weir RC and Dalgarno L: Ross
River virus variants selected during passage in chick embryo
fibroblasts: serological, genetic, and biological changes.
Virology. 193:446–449. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klimstra WB, Ryman KD and Johnston RE:
Adaptation of Sindbis virus to BHK cells selects for use of heparan
sulfate as an attachment receptor. J Virol. 72:7357–7366.
1998.PubMed/NCBI
|
|
16
|
Smit JM, Waarts BL, Kimata K, Klimstra WB,
Bittman R and Wilschut J: Adaptation of alphaviruses to heparan
sulfate: interaction of Sindbis and Semliki forest viruses with
liposomes containing lipid-conjugated heparin. J Virol.
76:10128–10137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Domingo E and Holland JJ: RNA virus
mutations and fitness for survival. Annu Rev Microbiol. 51:151–178.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hajjou M, Hill KR, Subramaniam SV, Hu JY
and Raju R: Nonhomologous RNA-RNA recombination events at the 3′
nontranslated region of the Sindbis virus genome: hot spots and
utilization of nonviral sequences. J Virol. 70:5153–5164. 1996.
|
|
19
|
Bredenbeek PJ, Frolov I, Rice CM and
Schlesinger S: Sindbis virus expression vectors: packaging of RNA
replicons by using defective helper RNAs. J Virol. 67:6439–6446.
1993.PubMed/NCBI
|
|
20
|
Ketola A, Schlesinger S and Wahlfors J:
Properties of Sindbis virus vectors produced with a chimeric split
helper system. Int J Mol Med. 15:999–1003. 2005.PubMed/NCBI
|
|
21
|
Lu X and Silver J: Transmission of
replication-defective Sindbis helper vectors encoding capsid and
envelope proteins. J Virol Methods. 91:59–65. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wahlfors JJ, Zullo SA, Loimas S, Nelson DM
and Morgan RA: Evaluation of recombinant alphaviruses as vectors in
gene therapy. Gene Ther. 7:472–480. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frolov I, Frolova E and Schlesinger S:
Sindbis virus replicons and Sindbis virus: assembly of chimeras and
of particles deficient in virus RNA. J Virol 1997. 71:2819–2829.
1997.PubMed/NCBI
|
|
24
|
Geigenmüller-Gnirke U, Weiss B, Wright R
and Schlesinger S: Complementation between Sindbis viral RNAs
produces infectious particles with a bipartite genome. Proc Natl
Acad Sci USA. 88:3253–3257. 1991.PubMed/NCBI
|
|
25
|
Weiss BG and Schlesinger S: Recombination
between Sindbis virus RNAs. J Virol. 65:4017–4025. 1991.PubMed/NCBI
|
|
26
|
Katze MG, He Y and Gale M Jr: Viruses and
interferon: a fight for supremacy. Nat Rev Immunol. 2:675–687.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goodbourn S, Didcock L and Randall RE:
Interferons: cell signalling, immune modulation, antiviral response
and virus countermeasures. J Gen Virol. 81:2341–2364.
2000.PubMed/NCBI
|
|
28
|
Laerum OD, Rajewsky MF, Schachner M, et
al: Phenotypic properties of neoplastic cell lines developed from
fetal rat brain cells in culture after exposure to ethylnitrosourea
in vivo. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol.
89:273–295. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rautsi O, Lehmusvaara S, Salonen T,
Häkkinen K, Sillanpää M, Hakkarainen T, Heikkinen S, Vähäkangas E,
Ylä-Herttuala S, Hinkkanen A, Julkunen I, Wahlfors J and Pellinen
R: Type I interferon response against viral and non-viral gene
transfer in human tumor and primary cell lines. J Gene Med.
9:122–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ronni T, Matikainen S, Sareneva T, Melén
K, Pirhonen J, Keskinen P and Julkunen I: Regulation of
IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene
expression in influenza A-infected human lung epithelial cells. J
Immunol. 158:2363–2374. 1997.
|
|
31
|
Ronni T, Melén K, Malygin A and Julkunen
I: Control of IFN-inducible MxA gene expression in human cells. J
Immunol. 150:1715–1726. 1993.PubMed/NCBI
|
|
32
|
Schlesinger S and Dubensky TW: Alphavirus
vectors for gene expression and vaccines. Curr Opin Biotechnol.
10:434–439. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Monroe SS and Schlesinger S: Common and
distinct regions of defective-interfering RNAs of Sindbis virus. J
Virol. 49:865–872. 1984.PubMed/NCBI
|
|
34
|
Galanis E, Vile R and Russell SJ: Delivery
systems intended for in vivo gene therapy of cancer: targeting and
replication competent viral vectors. Crit Rev Oncol Hematol.
38:177–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kew OM, Wright PF, Agol VI, Delpeyroux F,
Shimizu H, Nathanson N and Pallansch MA: Circulating
vaccine-derived polioviruses: current state of knowledge. Bull
World Health Organ. 82:16–23. 2004.PubMed/NCBI
|
|
36
|
Raju R, Subramaniam SV and Hajjou M:
Genesis of Sindbis virus by in vivo recombination of nonreplicative
RNA precursors. J Virol. 69:7391–7401. 1995.PubMed/NCBI
|
|
37
|
Berglund P, Sjöberg M, Garoff H, Atkins
GJ, Sheahan BJ and Liljeström P: Semliki Forest virus expression
system: production of conditionally infectious recombinant
particles. Biotechnology. 11:916–920. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Smerdou C and Liljeström P: Two-helper RNA
system for production of recombinant Semliki forest virus
particles. J Virol. 73:1092–1098. 1999.PubMed/NCBI
|
|
39
|
Wang KS, Kuhn RJ, Strauss EG, Ou S and
Strauss JH: High-affinity laminin receptor is a receptor for
Sindbis virus in mammalian cells. J Virol. 66:4992–5001.
1992.PubMed/NCBI
|
|
40
|
Castronovo V: Laminin receptors and
laminin-binding proteins during tumor invasion and metastasis.
Invasion Metastasis. 13:1–30. 1993.PubMed/NCBI
|
|
41
|
Martignone S, Ménard S, Bufalino R,
Cascinelli N, Pellegrini R, Tagliabue E, Andreola S, Rilke F and
Colnaghi MI: Prognostic significance of the 67-kilodalton laminin
receptor expression in human breast carcinomas. J Natl Cancer Inst.
85:398–402. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sobel ME: Differential expression of the
67 kDa laminin receptor in cancer. Semin Cancer Biol. 4:311–317.
1993.PubMed/NCBI
|
|
43
|
Tseng JC, Zanzonico PB, Levin B, Finn R,
Larson SM and Meruelo D: Tumor-specific in vivo transfection with
HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis
for prodrug ganciclovir activation and PET. J Nucl Med.
47:1136–1143. 2006.PubMed/NCBI
|
|
44
|
Everts B and van der Poel HG:
Replication-selective oncolytic viruses in the treatment of cancer.
Cancer Gene Ther. 12:141–161. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stojdl DF, Lichty B, Knowles S, Marius R,
Atkins H, Sonenberg N and Bell JC: Exploiting tumor-specific
defects in the interferon pathway with a previously unknown
oncolytic virus. Nat Med. 6:821–825. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Billiau A, Edy VG, Heremans H, Van Damme
J, Desmyter J, Georgiades JA and De Somer P: Human interferon: mass
production in a newly established cell line, MG-63. Antimicrob
Agents Chemother. 12:11–15. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gorchakov R, Frolova E and Frolov I:
Inhibition of transcription and translation in Sindbis
virus-infected cells. J Virol. 79:9397–9409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Frolova EI, Fayzulin RZ, Cook SH, Griffin
DE, Rice CM and Frolov I: Roles of nonstructural protein nsP2 and
Alpha/Beta interferons in determining the outcome of Sindbis virus
infection. J Virol. 76:11254–11264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ryman KD, Klimstra WB, Nguyen KB, Biron CA
and Johnston RE: Alpha/beta interferon protects adult mice from
fatal Sindbis virus infection and is an important determinant of
cell and tissue tropism. J Virol. 74:3366–3378. 2000. View Article : Google Scholar : PubMed/NCBI
|
